← Leaderboards
James P Allison
University Of California Berkeley
$8,082,148
Attributed
$8,082,148
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $782.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,082,148 · 10
By mechanism
P50$3,010,430 · 3
R01$2,490,506 · 2
T32$1,934,341 · 3
S10$500,000 · 1
P30$146,871 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- Laurel L Lenz$13,007,441
- David H Raulet$25,800,180
- Michel Dupage$4,220,441
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseClinical TrialsT-LymphocyteImmunotherapyCellsResponseMalignant NeoplasmsImmunologyTumorSuccessMalignant Neoplasm Of ProstateMemberPathway InteractionsImmuneLinkImmunologic MonitoringImmune SystemPatient SubsetsFundingCancer TherapyCancer CenterCancer ImmunotherapyMolecularBiological
Grant awards (41)
04 Immunology$24,692
P30 · FY2025 · CA · contact PI
04 Immunology$23,220
P30 · FY2024 · CA · contact PI
04 Immunology$18,707
P30 · FY2023 · CA · contact PI
04 Immunology$18,707
P30 · FY2022 · CA · contact PI
04 Immunology$18,707
P30 · FY2021 · CA · contact PI
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC$285,493
P50 · FY2020 · CA · contact PI
04 Immunology$18,675
P30 · FY2020 · CA · contact PI
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC$286,283
P50 · FY2019 · CA · contact PI
04 Immunology$18,707
P30 · FY2019 · CA · contact PI
04 Immunology$5,456
P30 · FY2019 · CA · contact PI
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC$304,980
P50 · FY2018 · CA · contact PI
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC$264,902
P50 · FY2017 · CA · contact PI
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC$322,278
P50 · FY2016 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$129,187
P50 · FY2015 · CA · contact PI
Training Program in Cancer Immunobiology$374,589
T32 · FY2014 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$127,465
P50 · FY2014 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$122,210
P50 · FY2013 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$134,838
P50 · FY2012 · CA · contact PI
Immunology Research Training$110,831
T32 · FY2011 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$217,517
P50 · FY2010 · CA · contact PI
Immunology Research Training$202,916
T32 · FY2010 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$216,298
P50 · FY2009 · CA · contact PI
Immunology Research Training$163,604
T32 · FY2009 · CA · contact PI
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$311,649
R01 · FY2008 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$247,975
P50 · FY2008 · CA · contact PI
Immunology Research Training$223,197
T32 · FY2008 · CA · contact PI
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$311,649
R01 · FY2007 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$243,062
P50 · FY2007 · CA · contact PI
Immunology Research Training$209,801
T32 · FY2007 · CA · contact PI
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$322,714
R01 · FY2006 · CA · contact PI
Immunology Research Training$206,417
T32 · FY2006 · CA · contact PI
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER$107,942
P50 · FY2006 · CA · contact PI
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$301,320
R01 · FY2005 · CA
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$303,660
R01 · FY2004 · CA
High Speed Cell Sorter$500,000
S10 · FY2002 · RR
Molecular Immunology &Tumor Biology$235,192
T32 · FY2002 · CA
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$242,056
R01 · FY2001 · CA
T CELL COSTIMULATION IN ANTITUMOR RESPONSES$234,188
R01 · FY2001 · CA
Molecular Immunology &Tumor Biology$207,794
T32 · FY2001 · CA
SURFACE ANTIGENS OF MURINE T LYMPHOMAS$235,008
R01 · FY2000 · CA
T CELL COSTIMULATION IN ANTITUMOR RESPONSES$228,262
R01 · FY2000 · CA